Pediatric Acute Kidney Injury Cases Increased Tenfold Over Past 25 Years

Hospitalizations made complex by intense kidney injury (AKI) rose amongst clients in pediatric systems or kids’s healthcare facilities over the previous 25 years, a big retrospective research study suggested.

Amongst more than 24.3 million discharges, hospitalizations including AKI increased significantly, increasing from 15.7 per 10,000 discharges in 1997 to 168.7 in 2022. Rates of AKI needing dialysis (AKI-D) more than folded the exact same duration, growing from 2.4 to 5.5 per 10,000 discharges.

National weighted yearly occurrence of AKI cases leapt from 6,318 to 63,923, while AKI-D cases increased from 981 to 2,075, reported Alexander Kula, MD, MHS, of Ann and Robert H. Lurie Children’s Hospital of Chicago, and coworkers in JAMA Network Open

In-hospital death amongst pediatric clients with AKI enhanced considerably, dropping from 1,814.0 to 643.4 per 10,000 hospitalizations in between 2003 and 2022. Death for clients needing dialysis stayed steady at roughly 25%.

Increasing AKI rates ought to not be seen “solely as worsening care,” warned Laura Rangel Rodriguez, MD, of Cincinnati Children’s Hospital Medical Center, and David Selewski, MD, of Arkansas Children’s Hospital in Little Rock, in an accompanying commentary

“Children with complex congenital heart disease, malignant neoplasms, transplants, and critical illness are surviving longer and being exposed to therapies and physiologic stressors that increase the risk of kidney injury,” they composed. “Increasing AKI rates may therefore reflect both improved case identification and the growing medical complexity of contemporary pediatric hospital care.”

Kula’s group concurred that increased acknowledgment and coding modifications partially describe the rise in AKI cases, though they noted this would not totally describe the increase in dialysis cases.

“The increase in AKI-D incidence may be a reflection of changes in the wider availability of dialysis devices and protocols suitable for infants or changes in physician practice patterns regarding willingness to initiate dialysis in increasing numbers of patients with AKI,” the scientists kept in mind. “It could also be secondary to an increase in the severity of AKI stemming from an increase in disease severity, multiple organ dysfunction, and requirement for technology use in hospitalized pediatric patients.”

Ramifications of the findings surpass hospitalization, Rangel Rodriguez and Selewski included. “Survivors of AKI and AKI-D face increased risks of chronic kidney disease, hypertension, recurrent AKI, and cardiovascular complications. Recognition of these long-term consequences has prompted increasing emphasis on post-AKI surveillance and longitudinal follow-up in children and neonates.”

Eventually, health care systems should develop sustainable methods to client education, shift preparation, and outpatient nephrology care as the swimming pool of AKI survivors broadens, they encouraged.

“These challenges are further amplified by workforce shortages in pediatric nephrology and highlight the need for robust neonatal and pediatric critical care nephrology programs,” the editorialists included. “Ensuring adequate resources for pediatric critical care nephrology and neonatal critical care nephrology programs is critical to continue to move the bar in this field.”

For the research study, the scientists examined information from the Healthcare Cost and Utilization Project Kids’ Inpatient Database (KID), a population-based sample of pediatric system and kids’s healthcare facility admissions launched every 3 years.

AKI and dialysis use were determined utilizing ICD-9-CM codes for KID releases from 1997 to 2012 and ICD-10-CM codes for releases from 2016 to 2022.

Throughout 24,344,876 consisted of discharges, an approximated 253,138 hospitalizations were made complex by AKI. The approximated mean age was 6.9 years, and 46.9% were male.

In 1997, the 3 most typical main medical diagnoses amongst AKI hospitalizations were malignancy (7.5%), cardiovascular conditions (6.7%), and hematologic or immune conditions (2.2%). By 2022, the leading main medical diagnoses were cardiovascular conditions (3.3%), deadly neoplasms (2.4%), and complicated medical innovation reliance (1.3%).

Over time, a greater percentage of AKI-related hospitalizations took place at big health centers and scholastic mentor. Throughout all study years, hospitalizations with AKI regularly had longer lengths of stay.

Since KID does not have patient-level tracking, some hospitalizations within a provided study year might represent readmissions of the exact same person, the authors acknowledged as a research study restriction.

“Future research should focus on testing the association of demographic and/or hospitalization covariables with AKI and AKI-D,” they concluded. “AKI should remain a priority for ongoing research and therapeutic innovation.”